Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal Fosfomycin, Metronidazole and Molgramostim in Perforated Appendicitis
NCT03435900Phase 2Completed
- Sponsor
- Herlev Hospital
- Start
- Feb 2018
- Primary completion
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim, fosfomycin in perforated appendicitis, sponsored by Herlev Hospital. Started Feb 2018; status: completed.
02
Drugs
sargramostimfosfomycin
03
Conditions
perforated appendicitis
Beyond the preview
Go deeper on NCT03435900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03435900.